Five days af­ter re­gain­ing the helm at Cure­Vac — and 1 day af­ter con­tro­ver­sy erupt­ed — In­g­mar Ho­err makes sur­prise ex­it

Five days ago, Cure­Vac founder and orig­i­nal CEO In­g­mar Ho­err grabbed back the reins at the Ger­man biotech, lat­er ex­plain­ing to us that at that point, with a glob­al coro­n­avirus cri­sis un­der­way, the com­pa­ny need­ed a sci­en­tist at the helm.

Yes­ter­day, word got out that the Trump ad­min­is­tra­tion was try­ing to co-opt the mR­NA tech that Cure­Vac had pi­o­neered, promis­ing it could de­vel­op a new vac­cine that could be quick­ly man­u­fac­tured for mil­lions of peo­ple. Eu­ro­pean au­thor­i­ties were livid at the idea of be­ing squeezed out by the US gov­ern­ment.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.